Pembrolizumab Plus Radiotherapy for Advanced Renal Cancer
NCT05567588
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
66
Enrollment
OTHER
Sponsor class
Conditions
Clear-cell Metastatic Renal Cell Carcinoma
Interventions
COMBINATION_PRODUCT:
Drug: Pembrolizumab
Sponsor
Nanfang Hospital, Southern Medical University